Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $34.2 Million - $39.8 Million
-165,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $34.2 Million - $45.6 Million
165,000 New
165,000 $39 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $7.34 Million - $9.85 Million
-44,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $7.31 Million - $8.23 Million
44,000 New
44,000 $7.45 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Voleon Capital Management LP Portfolio

Follow Voleon Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Voleon Capital Management LP with notifications on news.